These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 3901645)

  • 21. Prevention of mast cell activation disorder-associated clinical sequelae of excessive prostaglandin D(2) production.
    Butterfield JH; Weiler CR
    Int Arch Allergy Immunol; 2008; 147(4):338-43. PubMed ID: 18622141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Benign systemic mastocytosis: report of 2 cases].
    Velloso ED; Beitler B; Chamone DA
    Rev Hosp Clin Fac Med Sao Paulo; 1991; 46(2):94-8. PubMed ID: 1843375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An immunohistochemical study of the bone marrow lesions of systemic mastocytosis: expression of stem cell factor by lesional mast cells.
    Akin C; Jaffe ES; Raffeld M; Kirshenbaum AS; Daley T; Noel P; Metcalfe DD
    Am J Clin Pathol; 2002 Aug; 118(2):242-7. PubMed ID: 12162685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary 11β-PGF2α and N-methyl histamine correlate with bone marrow biopsy findings in mast cell disorders.
    Divekar R; Butterfield J
    Allergy; 2015 Oct; 70(10):1230-8. PubMed ID: 26095439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tryptase and histamine metabolites as diagnostic indicators of indolent systemic mastocytosis without skin lesions.
    van Doormaal JJ; van der Veer E; van Voorst Vader PC; Kluin PM; Mulder AB; van der Heide S; Arends S; Kluin-Nelemans JC; Oude Elberink JN; de Monchy JG
    Allergy; 2012 May; 67(5):683-90. PubMed ID: 22435702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cutaneous mastocytosis in Singapore.
    Tay YK; Giam YC
    Singapore Med J; 1993 Oct; 34(5):425-9. PubMed ID: 8153691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical detection of histidine decarboxylase in neoplastic mast cells in patients with systemic mastocytosis.
    Krauth MT; Agis H; Aichberger KJ; Simonitsch-Klupp I; Müllauer L; Mayerhofer M; Böhm A; Horny HP; Valent P
    Hum Pathol; 2006 Apr; 37(4):439-47. PubMed ID: 16564918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biology, classification and treatment of human mastocytosis.
    Valent P
    Wien Klin Wochenschr; 1996; 108(13):385-97. PubMed ID: 8766423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diffuse erythrodermic cutaneous mastocytosis with bone marrow infiltration.
    Olgun N; Oren H; Oren B; Irken G; Polat M; Cevik N
    Dermatology; 1993; 187(2):127-9. PubMed ID: 8358101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone marrow mast cell immunophenotyping in adults with mast cell disease: a prospective study of 33 patients.
    Pardanani A; Kimlinger T; Reeder T; Li CY; Tefferi A
    Leuk Res; 2004 Aug; 28(8):777-83. PubMed ID: 15203275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cutaneous and systemic manifestations of mastocytosis.
    Alto WA; Clarcq L
    Am Fam Physician; 1999 Jun; 59(11):3047-54, 3059-60. PubMed ID: 10392589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current approaches to the diagnosis and treatment of systemic mastocytosis.
    Bains SN; Hsieh FH
    Ann Allergy Asthma Immunol; 2010 Jan; 104(1):1-10; quiz 10-2, 41. PubMed ID: 20143640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Acute myelomonocytic leukemia with mastocytosis in bone marrow].
    Natori H; Nakamura E; Tanaka K; Naito K; Egami K; Honda J; Osabe S; Imamura Y; Natori K; Yasuda K
    Rinsho Ketsueki; 1990 Feb; 31(2):239-44. PubMed ID: 2329687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hematopathology of the bone marrow in pediatric cutaneous mastocytosis. A study of 17 patients.
    Kettelhut BV; Parker RI; Travis WD; Metcalfe DD
    Am J Clin Pathol; 1989 May; 91(5):558-62. PubMed ID: 2470248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased urinary histamine metabolite after successful PUVA treatment of urticaria pigmentosa.
    Granerus G; Roupe G; Swanbeck G
    J Invest Dermatol; 1981 Jan; 76(1):1-3. PubMed ID: 7462662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis of mastocytosis subsets using a morphometric point counting technique.
    Kasper CS; Freeman RG; Tharp MD
    Arch Dermatol; 1987 Aug; 123(8):1017-21. PubMed ID: 2443079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum tryptase and SCORMA (SCORing MAstocytosis) Index as disease severity parameters in childhood and adult cutaneous mastocytosis.
    Heide R; van Doorn K; Mulder PG; van Toorenenbergen AW; Beishuizen A; de Groot H; Tank B; Oranje AP
    Clin Exp Dermatol; 2009 Jun; 34(4):462-8. PubMed ID: 19077102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Ultrastructural findings in tissue mast cells in urticaria pigmentosa].
    Schmidt U; Leder LD
    Z Hautkr; 1988 Aug; 63(8):651-7. PubMed ID: 3188605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Mastocytosis: when should it be considered?].
    Comte-Perret S; Bart PA; Spertini F; Leimgruber A
    Rev Med Suisse; 2009 Apr; 5(199):837-42. PubMed ID: 19441750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The spectrum of mastocytosis.
    Tharp MD
    Am J Med Sci; 1985 Mar; 289(3):119-32. PubMed ID: 2579553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.